Evidence map›Paper›PMID 35349630›Full record

ArticleThe Journal of general physiology2022

Calcium current modulation by the γ1 subunit depends on alternative splicing of CaV1.1.

Yousra El Ghaleb, Nadine J Ortner, Wilfried Posch, Monica L Fernández-Quintero, Wietske E Tuinte, Stefania Monteleone, Henning J Draheim, Klaus R Liedl, Doris Wilflingseder, Jörg Striessnig and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of general physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Advances in CaChannels (Austin, Tex.) · 2023
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Yousra El GhalebInstitute of Physiology, Department of Physiology and Medical Physics, Medical University Innsbruck, Innsbruck, Austria.
Nadine J OrtnerDepartment of Pharmacology and Toxicology, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.ORCID 0000-0003-3882-3283
Wilfried PoschInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Monica L Fernández-QuinteroInstitute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.
Wietske E TuinteInstitute of Physiology, Department of Physiology and Medical Physics, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0003-0331-0402
Stefania MonteleoneInstitute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.
Henning J DraheimBoehringer Ingelheim Pharma GmbH & Co KG, CNS Research, Biberach an der Riss, Germany.ORCID 0000-0001-6018-8090
Klaus R LiedlInstitute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.
Doris WilflingsederInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-5888-5118
Jörg StriessnigDepartment of Pharmacology and Toxicology, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-9406-7120
Petronel TulucDepartment of Pharmacology and Toxicology, Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.ORCID 0000-0003-3660-6138
Bernhard E FlucherInstitute of Physiology, Department of Physiology and Medical Physics, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0002-5255-4705
Marta CampiglioInstitute of Physiology, Department of Physiology and Medical Physics, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0002-9629-2073
Innsbruck Medical University · ATUniversität Innsbruck · ATBoehringer Ingelheim (Germany) · DE

Funding

Austrian Science Fund FWF DOC 30Austrian Science Fund FWF P 27809Austrian Science Fund FWF P 30402Austrian Science Fund FWF P 33776Austrian Science Fund FWF P 35722Austrian Science Fund FWF T 855Austrian Science Fund FWF T855
6 · The paper itself

Abstract

The skeletal muscle voltage-gated calcium channel (CaV1.1) primarily functions as a voltage sensor for excitation-contraction coupling. Conversely, its ion-conducting function is modulated by multiple mechanisms within the pore-forming α1S subunit and the auxiliary α2δ-1 and γ1 subunits. In particular, developmentally regulated alternative splicing of exon 29, which inserts 19 amino acids in the extracellular IVS3-S4 loop of CaV1.1a, greatly reduces the current density and shifts the voltage dependence of activation to positive potentials outside the physiological range. We generated new HEK293 cell lines stably expressing α2δ-1, β3, and STAC3. When the adult (CaV1.1a) and embryonic (CaV1.1e) splice variants were expressed in these cells, the difference in the voltage dependence of activation observed in muscle cells was reproduced, but not the reduced current density of CaV1.1a. Only when we further coexpressed the γ1 subunit was the current density of CaV1.1a, but not that of CaV1.1e, reduced by >50%. In addition, γ1 caused a shift of the voltage dependence of inactivation to negative voltages in both variants. Thus, the current-reducing effect of γ1, unlike its effect on inactivation, is specifically dependent on the inclusion of exon 29 in CaV1.1a. Molecular structure modeling revealed several direct ionic interactions between residues in the IVS3-S4 loop and the γ1 subunit. However, substitution of these residues by alanine, individually or in combination, did not abolish the γ1-dependent reduction of current density, suggesting that structural rearrangements in CaV1.1a induced by inclusion of exon 29 may allosterically empower the γ1 subunit to exert its inhibitory action on CaV1.1 calcium currents.

Indexed as

Alternative SplicingCalciumCalcium Channels, L-TypeExcitation Contraction CouplingHEK293 CellsHumansCalciumCalcium Channels, L-Type

Identifiers

PMID35349630
PMCPMC9037348
OpenAlexW4220891328

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.